Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718. https://doi.org/10.1007/s00401-010-0781-z

Article  PubMed  Google Scholar 

Brendle C, Hempel JM, Schittenhelm J et al (2018) Glioma grading and determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion. Clin Neuroradiol 28:421–428. https://doi.org/10.1007/s00062-017-0590-z

Article  PubMed  Google Scholar 

Venneti S, Huse JT (2015) The evolving molecular genetics of low-grade glioma. Adv Anat Pathol 22:94–101. https://doi.org/10.1097/PAP.0000000000000049

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ogishima T, Tamura K, Kobayashi D et al (2017) ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations. Brain Tumor Pathol 34:20–27. https://doi.org/10.1007/s10014-017-0280-1

Article  CAS  PubMed  Google Scholar 

Alexiou GA, Tsiouris S, Kyritsis AP, Argyropoulou MI, Voulgaris S, Fotopoulos AD (2010) Assessment of glioma proliferation using imaging modalities. J Clin Neurosci 17:1233–1238. https://doi.org/10.1016/j.jocn.2010.03.021

Article  PubMed  Google Scholar 

Cai K, Haris M, Singh A et al (2012) Magnetic resonance imaging of glutamate. Nat Med 18:302–306. https://doi.org/10.1038/nm.2615

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heo HY, Lee DH, Zhang Y et al (2017) Insight into the quantitative metrics of chemical exchange saturation transfer (CEST) imaging. Magn Reson Med 77:1853–1865. https://doi.org/10.1002/mrm.26264

Article  CAS  PubMed  Google Scholar 

Cai K, Singh A, Poptani H et al (2015) CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed 28:1–8. https://doi.org/10.1002/nbm.3216

Article  CAS  PubMed  Google Scholar 

Wu M, Jiang T, Guo M et al (2023) Amide Proton transfer-weighted imaging and derived radiomics in the classification of adult-type diffuse gliomas. Eur Radiol. https://doi.org/10.1007/s00330-023-10343-6

Article  PubMed  PubMed Central  Google Scholar 

Hou H, Chen W, Diao Y et al (2023) 3D Amide Proton transfer-weighted imaging for Grading Glioma and correlating IDH Mutation Status: added value to 3D pseudocontinuous arterial spin labelling perfusion. Mol Imaging Biol 25:343–352. https://doi.org/10.1007/s11307-022-01762-w

Article  CAS  PubMed  Google Scholar 

Guo H, Liu J, Hu J et al (2022) Diagnostic performance of gliomas grading and IDH status decoding a comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models. J Magn Reson Imaging 56:1834–1844. https://doi.org/10.1002/jmri.28211

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Ke C, Liu J et al (2021) Diagnostic performance between MR Amide Proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T. Eur J Radiol 134:109466. https://doi.org/10.1016/j.ejrad.2020.109466

Article  PubMed  Google Scholar 

Mancini L, Casagranda S, Gautier G et al (2022) CEST MRI provides amide/amine surrogate biomarkers for treatment-naive glioma sub-typing. Eur J Nucl Med Mol Imaging 49:2377–2391. https://doi.org/10.1007/s00259-022-05676-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sakata A, Okada T, Yamamoto A et al (2015) Grading glial tumors with amide proton transfer MR imaging: different analytical approaches. J Neurooncol 122:339–348. https://doi.org/10.1007/s11060-014-1715-8

Article  CAS  PubMed  Google Scholar 

Zaiss M, Schmitt B, Bachert P (2011) Quantitative separation of CEST effect from magnetization transfer and spillover effects by Lorentzian-line-fit analysis of z-spectra. J Magn Reson 211:149–155. https://doi.org/10.1016/j.jmr.2011.05.001

Article  CAS  PubMed  Google Scholar 

Su C, Zhao L, Li S et al (2019) Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI). Eur Radiol 29:1203–1210. https://doi.org/10.1007/s00330-018-5615-8

Article  PubMed  Google Scholar 

Zhao Y, Sun C, Zu Z (2023) Assignment of molecular origins of NOE signal at -3.5 ppm in the brain. Magn Reson Med 90:673–685. https://doi.org/10.1002/mrm.29643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reuss DE, Sahm F, Schrimpf D et al (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129:133–146. https://doi.org/10.1007/s00401-014-1370-3

Article  CAS  PubMed  Google Scholar 

Zhang Y, Heo HY, Lee DH et al (2016) Selecting the reference image for registration of CEST series. J Magn Reson Imaging 43:756–761. https://doi.org/10.1002/jmri.25027

Article  PubMed  Google Scholar 

Stancanello J, Terreno E, Castelli DD, Cabella C, Uggeri F, Aime S (2008) Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging 3:136–149. https://doi.org/10.1002/cmmi.240

Article  CAS  PubMed  Google Scholar 

Windschuh J, Zaiss M, Meissner JE et al (2015) Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at 7 T. NMR Biomed 28:529–537. https://doi.org/10.1002/nbm.3283

Article  PubMed  Google Scholar 

Su C, Xu S, Lin D et al (2022) Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients. Eur Radiol 32:101–111. https://doi.org/10.1007/s00330-021-08175-3

Article  CAS  PubMed  Google Scholar 

Pencina MJ, D’Agostino RS, D’Agostino RJ, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172. https://doi.org/10.1002/sim.2929

Article  PubMed  Google Scholar 

Kim H, Kim J, Sun PZ (2023) CEST2022 - mapping multi-pool CEST signal changes in an animal model of brain tumor with quasi-steady-state reconstruction-empowered CEST quantification. Magn Reson Imaging 102:229–234. https://doi.org/10.1016/j.mri.2023.06.005

Article  PubMed  Google Scholar 

Jin T, Wang P, Zong X, Kim SG (2013) MR imaging of the amide-proton transfer effect and the pH-insensitive nuclear overhauser effect at 9.4 T. Magn Reson Med 69:760–770. https://doi.org/10.1002/mrm.24315

Article  CAS  PubMed  Google Scholar 

Zu Z (2018) Towards the complex dependence of MTR(asym) on T(1w) in amide proton transfer (APT) imaging. NMR Biomed 31:e3934. https://doi.org/10.1002/nbm.3934

Article  PubMed  PubMed Central  Google Scholar 

Lee DH, Heo HY, Zhang K et al (2017) Quantitative assessment of the effects of water proton concentration and water T(1) changes on amide proton transfer (APT) and nuclear overhauser enhancement (NOE) MRI: the origin of the APT imaging signal in brain tumor. Magn Reson Med 77:855–863. https://doi.org/10.1002/mrm.26131

Article  CAS  PubMed